196 related articles for article (PubMed ID: 25729033)
1. Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
Steiman AJ; Urowitz MB; Ibañez D; Li TT; Gladman DD; Wither J
J Rheumatol; 2015 May; 42(5):810-6. PubMed ID: 25729033
[TBL] [Abstract][Full Text] [Related]
2. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
Ng KP; Manson JJ; Rahman A; Isenberg DA
Arthritis Rheum; 2006 Dec; 55(6):900-4. PubMed ID: 17139667
[TBL] [Abstract][Full Text] [Related]
3. The antichromatin antibodies can be useful as a diagnostic tool and disease activity marker of systemic lupus erythematosus in Koreans.
Kim HA; Jeon JY; Choi GS; Sung JM; Kim MJ; Yun JM; Suh CH
Clin Immunol; 2008 Aug; 128(2):277-83. PubMed ID: 18504161
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.
Förger F; Matthias T; Oppermann M; Becker H; Helmke K
Lupus; 2004; 13(1):36-44. PubMed ID: 14870916
[TBL] [Abstract][Full Text] [Related]
5. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
[TBL] [Abstract][Full Text] [Related]
6. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
7. Constant isotype pattern of anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Winkler TH; Henschel TA; Kalies I; Baenkler HW; Skvaril F; Kalden JR
Clin Exp Immunol; 1988 Jun; 72(3):434-9. PubMed ID: 3262461
[TBL] [Abstract][Full Text] [Related]
8. Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flares.
Walz LeBlanc BA; Gladman DD; Urowitz MB
J Rheumatol; 1994 Dec; 21(12):2239-41. PubMed ID: 7699623
[TBL] [Abstract][Full Text] [Related]
9. The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.
Tseng CE; Buyon JP; Kim M; Belmont HM; Mackay M; Diamond B; Marder G; Rosenthal P; Haines K; Ilie V; Abramson SB
Arthritis Rheum; 2006 Nov; 54(11):3623-32. PubMed ID: 17075807
[TBL] [Abstract][Full Text] [Related]
10. Antibody clustering helps refine lupus prognosis.
Kessel A; Rosner I; Halasz K; Grushko G; Shoenfeld Y; Paran D; Toubi E
Semin Arthritis Rheum; 2009 Aug; 39(1):66-70. PubMed ID: 18538829
[TBL] [Abstract][Full Text] [Related]
11. Quantitation and IgG subclass distribution of antichromatin autoantibodies in SLE mice.
Fisher CL; Eisenberg RA; Cohen PL
Clin Immunol Immunopathol; 1988 Feb; 46(2):205-13. PubMed ID: 3338193
[TBL] [Abstract][Full Text] [Related]
12. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
Bhat NM; Lee LM; van Vollenhoven RF; Teng NN; Bieber MM
J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320
[TBL] [Abstract][Full Text] [Related]
13. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
14. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
Sjoholm AG; Martensson U; Sturfelt G
J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075
[TBL] [Abstract][Full Text] [Related]
15. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
16. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus.
Ho A; Magder LS; Barr SG; Petri M
Arthritis Rheum; 2001 Oct; 44(10):2342-9. PubMed ID: 11665975
[TBL] [Abstract][Full Text] [Related]
17. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
Guo H; Leung JC; Chan LY; Chan TM; Lai KN
Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
[TBL] [Abstract][Full Text] [Related]
18. Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates.
Caccavo D; Rigon A; Picardi A; Galluzzo S; Vadacca M; Ferri GM; Amoroso A; Afeltra A
Clin Rheumatol; 2005 Aug; 24(4):381-7. PubMed ID: 15592902
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
20. Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome.
Steiman AJ; Gladman DD; Ibañez D; Urowitz MB
J Rheumatol; 2010 Sep; 37(9):1822-7. PubMed ID: 20595281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
